Literature DB >> 12615256

Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure.

Benjamin H Trichon1, G Michael Felker, Linda K Shaw, Christopher H Cabell, Christopher M O'Connor.   

Abstract

The goal of this study was to examine the frequency of mitral regurgitation (MR) in patients with left ventricular (LV) systolic dysfunction and to relate its presence and severity to long-term survival. Remodeling of the left ventricle after myocyte injury leads to a progressive change in LV size and shape, and it may lead to the development of MR. The frequency of MR and its relation to survival in patients with LV systolic dysfunction has not been completely characterized. We analyzed the histories, coronary anatomy, and degree of MR in patients with symptomatic heart failure and LV ejection fraction <40% who underwent cardiac catheterization between 1986 and 2000. Cox's proportional hazards modeling was used to assess the independent effect of MR on survival. Two thousand fifty-seven patients met study criteria; MR was common in this cohort (56.2%). Of patients with MR, 811 (70.1%) had mild (grades 1+ or 2+) and 345 (29.8%) had moderate or severe (grades 3+ or 4+) regurgitation. Survival rates at 1, 3, and 5 years were significantly lower in patients with moderate to severe MR versus those with mild or no MR (p <0.001). MR was found to be an independent predictor of mortality after multivariable analysis (hazards ratio 1.23, 95% confidence interval 1.13 to 1.34, p = 0.0001). This relation of MR and survival was present in those with ischemic and nonischemic cardiomyopathies. MR is common in patients with LV systolic dysfunction and heart failure. After adjusting for other clinical variables, the presence of MR independently predicted worsened survival.

Entities:  

Mesh:

Year:  2003        PMID: 12615256     DOI: 10.1016/s0002-9149(02)03301-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  117 in total

1.  Mitral valve analysis using a novel 3D holographic display: a feasibility study of 3D ultrasound data converted to a holographic screen.

Authors:  Jan Otto Beitnes; Lars Gunnar Klæboe; Jørn Skaarud Karlsen; Stig Urheim
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-13       Impact factor: 2.357

Review 2.  Surgical approach to mitral regurgitation in chronic heart failure: when is it an option?

Authors:  Juan A Crestanello
Journal:  Curr Heart Fail Rep       Date:  2012-03

3.  Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2.

Authors:  Jiri Petrak; Jana Pospisilova; Miroslava Sedinova; Petr Jedelsky; Lucie Lorkova; Ondrej Vit; Michal Kolar; Hynek Strnad; Jan Benes; David Sedmera; Ludek Cervenka; Vojtech Melenovsky
Journal:  Proteome Sci       Date:  2011-11-11       Impact factor: 2.480

4.  Distinct but parallel evolutionary patterns between alcohol and aldehyde dehydrogenases: addition of fish/human betaine aldehyde dehydrogenase divergence.

Authors:  L Hjelmqvist; A Norin; M El-Ahmad; W Griffiths; H Jörnvall
Journal:  Cell Mol Life Sci       Date:  2003-09       Impact factor: 9.261

5.  Deep sedation versus general anesthesia in percutaneous edge-to-edge mitral valve reconstruction using the MitraClip system.

Authors:  Suzanne de Waha; Joerg Seeburger; Joerg Ender; Steffen Desch; Ingo Eitel; Adrian Reinhardt; Janine Pöss; Georg Fuernau; Thilo Noack; Denis Rouven Merk; Gerhard Schuler; Hans-Hinrich Sievers; Friedrich-Wilhelm Mohr; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2015-12-18       Impact factor: 5.460

6.  Semi-automated mitral valve morphometry and computational stress analysis using 3D ultrasound.

Authors:  Alison M Pouch; Chun Xu; Paul A Yushkevich; Arminder S Jassar; Mathieu Vergnat; Joseph H Gorman; Robert C Gorman; Chandra M Sehgal; Benjamin M Jackson
Journal:  J Biomech       Date:  2012-01-26       Impact factor: 2.712

Review 7.  Pathophysiology of ischemic mitral insufficiency: does repair make a difference?

Authors:  Joseph H Gorman; Liam P Ryan; Robert C Gorman
Journal:  Heart Fail Rev       Date:  2006-09       Impact factor: 4.214

Review 8.  The Evolving Role of Percutaneous Mitral Valve Repair.

Authors:  Merrill H Stewart; J Stephen Jenkins
Journal:  Ochsner J       Date:  2016

9.  [Mitral regurgitation in heart failure. Surgical therapy].

Authors:  H Aubin; H Kamiya; A Lichtenberg
Journal:  Herz       Date:  2013-03       Impact factor: 1.443

10.  Impact of cardiac comorbidities on early and 1-year outcome after percutaneous mitral valve interventions: data from the German transcatheter mitral valve interventions (TRAMI) registry.

Authors:  Carsten Schwencke; Klaudija Bijuklic; Taoufik Ouarrak; Edith Lubos; Wolfgang Schillinger; Björn Plicht; Holger Eggebrecht; Stephan Baldus; Gerhard Schymik; Peter Boekstegers; Rainer Hoffmann; Jochen Senges; Joachim Schofer
Journal:  Clin Res Cardiol       Date:  2016-10-17       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.